Patent Opposition Database

Pneumococcal Conjugate Vaccine (PCV)

Type: Drug Disease: Pneumonia Countries: India and Korea (Republic of) Related documents: 21

Pneumococcal Conjugate Vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2007/071786)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2007/071786)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/100151)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/100151)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine application, (WO/2011/151760)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2182/DELNP/2015)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2183/DELNP/2015)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (KR1298053)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: Korea (Republic of)

Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (2533/KOLNP/2008)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (6666/CHENP/2012)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal Conjugate Vaccine decision, (8081/DELNP/2007)

Type: Patent office decision Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Pneumococcal conjugate vaccine application, (WO/2006/110381)

Type: Patent application Drugs: Pneumococcal Conjugate Vaccine Disease: pneumonia Countries: India

Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

antibodies. It was observed that regardless of the vaccine based on conjugate polysaccharides, a maximum load any other protein exists

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Merck, Novartis, Crucell Holand, Dr.Franz-Josef and Strawman opposition, Pneumococcal Conjugate Vaccine, (EP 1868645)

that the valency of the experimental heptavalent conjugate vaccine can be increased by adding up to 5 more serotypes without indicating the type of carrier

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)

except 6B for which the target value is 8.8 ug/mL?. Further on page 14 it is specified that ?13-Valent Pneumococcal Conjugate (Prevnar 13) vaccine

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (KR1298053)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: Korea (Republic of)

Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)

Type: Patent opposition Drugs: Pneumococcal Conjugate Vaccine Disease: Pneumonia Countries: India

Tozinameran (BNT162b2 (NA)

Tozinameran is a Covid-19 messenger RNA based vaccine used to prevent Covid-19 infection.

Type: Drug Disease: Covid-19 Countries: Argentina Related documents: 1

Fundación Grupo Efecto Positivo opposition, Tozinameran (BNT162b2) COVID-19 mRNA vaccine, (P20210101008 (AR121859A1))

conjugado), (DSPC) colesterol 65-50 Amie. ALC-0159 CH, - a 4 i Colesterol SS, DSPC Figura 4. Lipidos de la rv. 24 de la presente solicitud cva. M. Lorena

Type: Patent opposition Drugs: Tozinameran (BNT162b2 Disease: Covid-19 Countries: Argentina

LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)

. F Zakir, Farah Islam , A Jabeen , SS Moni. Vaccine development: A historical perspective. Biomedical Research, April 2019; 30(3):452-455. IF-0.219

Type: Patent opposition Drugs: Emtricitabine/Tenofovir alafenamide fumarate (Descovy Disease: HIV Countries: India

Balaji R opposition, Elexacaftor, (201737015848)

such as Oral Rehydration Therapy (ORT), supportive renal therapy, administration of an antiviral, vaccine, or other compound to treat the underlying

Type: Patent opposition Drugs: Elexacaftor, Tezacaftor and Ivacator [Trikafta Disease: cystic fibrosis Countries: India